Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Gary M, Ansel"'
Publikováno v:
CVIR Endovascular, Vol 2, Iss 1, Pp 1-3 (2019)
Externí odkaz:
https://doaj.org/article/a65ce2a2f38340d6b84626cab18475e5
Publikováno v:
International Journal of Vascular Medicine, Vol 2019 (2019)
The Sentry inferior vena cava (IVC) filter is designed to provide temporary protection against pulmonary embolism (PE) during transient high-risk periods and then to bioconvert after 60 days after implantation. At the time of bioconversion, the devic
Externí odkaz:
https://doaj.org/article/cf88cc68a8e445b18f7cc3cf1baf2933
Autor:
Thomas Zeller, Marianne Brodmann, Gary M. Ansel, Dierk Scheinert, Donghoon Choi, Gunnar Tepe, Jeremiah Menk, Antonio Micari
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 18(11)
Numerous randomised controlled trials (RCTs) have demonstrated the superiority of paclitaxel drug-coated balloons (DCBs) over non-coated angioplasty balloons for treatment of femoropopliteal peripheral arterial disease (PAD). There is a paucity of cl
Autor:
William A. Gray, Jihad Mustapha, E. Hope Weissler, Jennifer A. Rymer, Gary M. Ansel, Manesh R. Patel, Eric A. Secemsky, George L. Adams, Dennis I. Narcisse, Ehrin J. Armstrong, W. Schuyler Jones
Publikováno v:
Vasc Endovascular Surg
Purpose: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention.
Autor:
Xiaohui Jiang, Michael D. Dake, Erin E. O’Leary, Aaron E. Lottes, Heidi Reichert, Thomas Zeller, Kan Zen, Gary M. Ansel, Osamu Iida, Marc L. Schermerhorn, Fabrizio Fanelli, Weiguo Fu
Publikováno v:
Cardiovascular and Interventional Radiology
Purpose Develop a prediction model to determine the impact of patient and lesion factors on freedom from target lesion revascularization (ffTLR) for patients who are candidates for Zilver PTX drug-eluting stent (DES) treatment for femoropopliteal les
Autor:
Antonio Micari, Yoshimitsu Soga, Mehdi H. Shishehbor, Laura Mauri, Kenneth Ouriel, Prakash Krishnan, Qi Gao, Marianne Brodmann, Thomas Zeller, John R. Laird, Gary M. Ansel, Peter Schneider
Publikováno v:
Catheterization and Cardiovascular Interventions. 96:1087-1099
BACKGROUND Paclitaxel drug-coated balloons (DCB) prevent recurrent claudication after angioplasty, yet data from randomized trials with incomplete follow-up have raised uncertainty regarding long-term mortality. OBJECTIVES To evaluate the effect of p
Autor:
William S Jones, George L. Adams, Ehrin J. Armstrong, William A. Gray, Jihad Mustapha, Eric A. Secemsky, Dennis I. Narcisse, Gary M. Ansel, Elizabeth Hope Weissler, Manesh R. Patel, Jennifer A. Rymer
Publikováno v:
Clinical Cardiology
BACKGROUND Patients with chronic kidney disease (CKD) have worsened clinical outcomes following percutaneous coronary intervention; however, limited evidence exists in patients undergoing peripheral vascular intervention (PVI). PURPOSE We aimed to as
Autor:
Krishna J. Rocha-Singh, Sean P. Lyden, Sanjay Misra, Christopher J. White, Joshua A. Beckman, Michael R. Jaff, John P. A. Ioannidis, Sue Duval, Christopher M. Mullin, Elazer R. Edelman, Gary M. Ansel, Juan F. Granada, Abraham R. Tzafriri, Peter Schneider
Publikováno v:
Circulation
Background: Paclitaxel-containing devices (PTXDs) significantly reduce reintervention in patients with symptomatic femoropopliteal peripheral artery disease. A recent aggregate-data meta-analysis reported increased late mortality in patients with per
Autor:
Antonio Micari, John R. Laird, Mehdi H. Shishehbor, Gheorghe Doros, Gunnar Tepe, Marianne Brodmann, Thomas Zeller, Gary M. Ansel, Peter Schneider, Qi Gao
Publikováno v:
Journal of the American College of Cardiology. 73:2550-2563
Background: Five years of prospective clinical trials confirm that the paclitaxel drug-coated balloon (DCB) (IN.PACT Admiral, Medtronic, Dublin, Ireland) is safe and effective to treat femo...
Autor:
Michael R. Jaff, George L. Adams, Gary M. Ansel, Brad J. Martinsen, William A. Gray, Jihad Mustapha, Ryan W. Bolduan
Publikováno v:
Journal of Endovascular Therapy
Purpose: To report the 1-year results of a multicenter study of peripheral artery disease (PAD) treatment with a variety of endovascular treatment strategies employed in routine practice. Materials and Methods: The LIBERTY trial ( ClinicalTrials.gov